New Concepts in the Management of Medullary Thyroid Cancer - Management of MEN2

December 11, 2013

This live webinar series is an educational program that addresses health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with medullary thyroid cancer (MTC). Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most current treatment recommendations for MTC and MEN2.

Target Audience

This webinar series  is designed to meet the educational needs of medical oncologists, surgical oncologists, radiation oncologists, endocrinologists, nurses, pharmacists, and other healthcare professionals who manage patients with thyroid cancer.

Learning Objectives

Following this activity, participants should be able to:
  • Summarize the recommendations for genetic testing and early intervention for patients with inherited MEN2 who are at risk for MTC
  • Recognize the different levels of risk for acquiring MTC for patients with specific RET gene mutations
Additional information
Supporters: 
Supported by educational grants from:
  • AstraZeneca LP
  • Exelixis, Inc.
Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
12/09/2013
Course expires: 
02/26/2014
Event starts: 
12/11/2013 - 1:00pm EST
Event ends: 
12/11/2013 - 2:00pm EST
Cost:
$0.00

Whitney S. Goldner, MD
Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center

This activity is approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits are also provided. View complete accreditation information

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
  • Adobe Reader or other PDF reader software for certificate viewing/printing